Moloney Securities Asset Management LLC Grows Position in Roche Holding AG (OTCMKTS:RHHBY)

Moloney Securities Asset Management LLC grew its holdings in shares of Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 53.8% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 40,732 shares of the company's stock after acquiring an additional 14,245 shares during the period. Moloney Securities Asset Management LLC's holdings in Roche were worth $1,672,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of RHHBY. Altrius Capital Management Inc increased its holdings in Roche by 3.6% in the first quarter. Altrius Capital Management Inc now owns 189,993 shares of the company's stock valued at $7,818,000 after purchasing an additional 6,545 shares during the period. Riverbridge Partners LLC grew its holdings in Roche by 6.7% during the 1st quarter. Riverbridge Partners LLC now owns 37,826 shares of the company's stock worth $1,557,000 after acquiring an additional 2,381 shares during the period. Bard Financial Services Inc. grew its holdings in Roche by 25.3% during the 1st quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock worth $5,716,000 after acquiring an additional 28,050 shares during the period. GAMMA Investing LLC grew its holdings in Roche by 59.5% during the 1st quarter. GAMMA Investing LLC now owns 12,850 shares of the company's stock worth $529,000 after acquiring an additional 4,794 shares during the period. Finally, Fulton Bank N.A. grew its holdings in Roche by 2.6% during the 1st quarter. Fulton Bank N.A. now owns 12,620 shares of the company's stock worth $518,000 after acquiring an additional 314 shares during the period.

Roche Stock Performance

Shares of OTCMKTS:RHHBY traded up $0.35 during trading on Thursday, reaching $41.22. 584,492 shares of the stock traded hands, compared to its average volume of 2,497,847. The stock has a 50-day moving average of $40.10 and a two-hundred day moving average of $39.62. Roche Holding AG has a 52-week low of $34.10 and a 52-week high of $44.31. The company has a current ratio of 1.48, a quick ratio of 1.20 and a debt-to-equity ratio of 0.85.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. HSBC cut shares of Roche from a "buy" rating to a "hold" rating in a research report on Monday, April 28th. Hsbc Global Res cut shares of Roche from a "strong-buy" rating to a "hold" rating in a research report on Monday, April 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, one has given a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy".

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.